Decreased levels of metalloproteinase-9 and angiogenic factors in skin lesions of patients with psoriatic arthritis after therapy with anti-TNF-alpha.

Decreased levels of metalloproteinase-9 and angiogenic factors in skin lesions of patients with psoriatic arthritis after therapy with anti-TNF-alpha.

Item
http://www.wikidata.org/entity/Q38582187
IL-1F5, -F6, -F8, and -F9: a novel IL-1 family signaling system that is active in psoriasis and promotes keratinocyte antimicrobial peptide expressionExtracellular matrix modulates angiogenesis in physiological and pathological conditions.A Potential Role for Mononuclear Phagocytes in Cutaneous Ulcer Development in Human Immunodeficiency Virus-Leishmania braziliensis Coinfection.Notch signalling pathways mediate synovial angiogenesis in response to vascular endothelial growth factor and angiopoietin 2Angiogenesis drives psoriasis pathogenesis.Anti-TNF-α agents in the treatment of immune-mediated inflammatory diseases: mechanisms of action and pitfalls.Leptin deficiency in mice counteracts imiquimod (IMQ)-induced psoriasis-like skin inflammation while leptin stimulation induces inflammation in human keratinocytes.Doxycycline as an anti-inflammatory agent: updates in dermatology.The Increased Expression of Matrix Metalloproteinase-9 Messenger RNA in the Non-lesional Skin of Patients with Large Plaque Psoriasis Vulgaris.Angiogenesis Dysregulation in Psoriatic Arthritis: Molecular Mechanisms.Influence of infliximab on keratinocyte apoptosis in psoriasis patients.The effects of infliximab or adalimumab on vascular endothelial growth factor and angiopoietin 1 angiogenic factor levels in inflammatory bowel disease: serial observations in 37 patients.Psoriasis, Cardiovascular Events, and Biologics: Lights and ShadowsEffective Therapy with Anti-TNF- in Patients with Psoriatic Arthritis Is Associated with Decreased Levels of Metalloproteinases and Angiogenic Cytokines in the Sera and Skin Lesions
P2860

Decreased levels of metalloproteinase-9 and angiogenic factors in skin lesions of patients with psoriatic arthritis after therapy with anti-TNF-alpha.

Item
http://www.wikidata.org/entity/Q38582187
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Decreased levels of metallopro ...... r therapy with anti-TNF-alpha.
@en
type
label
Decreased levels of metallopro ...... r therapy with anti-TNF-alpha.
@en
prefLabel
Decreased levels of metallopro ...... r therapy with anti-TNF-alpha.
@en
P1433
P1476
P2093
P2860
P2888
P304
P31
P356
P478
P50
P577
P5875
P6179
P698
P921
P932
P356
P1433
P1476
Decreased levels of metallopro ...... r therapy with anti-TNF-alpha.
@en
P2093
P2860
P2888
P304
P31
P356
P478
P50
P577
P5875
P6179
P698
P921
P932